Publications by authors named "Chebli Julio"

Claim this Profile
C
Clinical effectiveness and safety of vedolizumab versus infliximab in biologic-naïve patients with ulcerative colitis: A comparative real-world multicentric observational study.
Sandro da Costa Ferreira, Rogério Serafim Parra, Ligia Yukie Sassaki, José Miguel Luz Parente, Munique Kurtz de Mello

Gastroenterol Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positioning and sequencing of advanced therapies in inflammatory bowel disease: A guide for clinical practice.
Marcello Imbrizi, Matheus F C Azevedo, Julio P Baima, Natália S F Queiroz, Rogério S Parra, Julio Maria F Chebli

World J Gastroenterol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Intriguing Case of Hepatosplenic Lesions and Pneumonia During Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease.
Gabriel Luiz de Almeida Souza, Vinicius Andrade Chebli, Julio Maria Fonseca Chebli

Gastroenterology· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib for ulcerative colitis in Brazil: a multicenter observational study on effectiveness and safety.
Rogério Serafim Parra, Renata de Sá Brito Fróes, Daniela Oliveira Magro, Sandro da Costa Ferreira, Munique Kurtz de Mello

BMC Gastroenterol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHONDROITIN SULFATE AND GLUCOSAMINE SULFATE AS PROTECTIVE AND ANTI-INFLAMMATORY AGENTS IN THE ULCERATIVE COLITIS DSS MODEL IN RATS.
Luiz Gustavo de Oliveira, Arthur Girardi Carpanez, João Victor Gerheim da Silva, Maria Christina Marques Nogueira Castañon, Julio Maria Fonseca Chebli

Arq Gastroenterol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic dysfunction-associated steatotic liver disease prevalence and risk factors in inflammatory bowel disease in tertiary center.
Lívia Dos Remédios Pamplona de Oliveira, Tarsila Campanha da Rocha Ribeiro, Carlos Alberto Mourao Junior, Maria Antônia de Lima Barra, Mariana Hippert Gonçalves Silva

Rev Assoc Med Bras (1992)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASSESSMENT OF QUALITY OF LIFE IN ELDERLY PATIENTS WITH INFLAMMATORY BOWEL DISEASE WITH MILD ACTIVITY AND IN CLINICAL REMISSION.
João Baptista de Paula Fraga, Alexandre Ferreira Oliveira, Tarsila Campanha da Rocha Ribeiro, Lucélia Paula Cabral Schmidt, Gabriela Teixeira da Silva, Julio Maria Fonseca Chebli

Arq Gastroenterol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fecal calprotectin and endoscopic scores: The cornerstones in clinical practice for evaluating mucosal healing in inflammatory bowel disease.
Marcia Henriques de Magalhães Costa, Ligia Yukie Sassaki, Júlio Maria Fonseca Chebli

World J Gastroenterol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of Ustekinumab for Ulcerative Colitis: A Brazilian Multicentric Observational Study.
Rogério Serafim Parra, Júlio Maria Fonseca Chebli, Matheus Freitas Cardoso de Azevedo, Liliana Andrade Chebli, Gilmara Pandolfo Zabot

Crohns Colitis 360· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction between diet and genetics in patients with inflammatory bowel disease.
Daniéla Oliveira Magro, Ligia Yukie Sassaki, Júlio Maria Fonseca Chebli

World J Gastroenterol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined clinical and radiological remission of rectovaginal fistulas using fractional CO2 vaginal laser: a case series and medium-term follow-up.
Denise Gasparetti Drumond, Camila de Moraes Sarmento Condé, Júlio Maria da Fonseca Chebli, Liliana Andrade Chebli, Samuel Drumond Esperança

BMC Res Notes· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vedolizumab in Mild-to-Moderate Crohn's Disease Patients Naïve to Biological Therapy: A Multicentric Observational Study.
Adriana Zanoni Dotti, Daniela Oliveira Magro, Eduardo Garcia Vilela, Julio Maria Fonseca Chebli, Liliana Andrade Chebli

Crohns Colitis 360· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Pharmacogenetics in the Therapeutic Response to Thiopurines in the Treatment of Inflammatory Bowel Disease: A Systematic Review.
Aline C Ribeiro, Pâmela S A S Gerheim, Julio Maria Fonseca Chebli, Jorge Willian L Nascimento, Priscila de Faria Pinto

J Clin Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Early Optimization of Infliximab Guided by Therapeutic Drug Monitoring during Induction-A Prospective Trial.
Karoline Soares Garcia, Matheus Freitas Cardoso de Azevedo, Alexandre de Sousa Carlos, Luísa Leite Barros, Jane Oba

Biomedicines· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF CROHN'S DISEASE IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).
Marcello Imbrizi, Júlio Pinheiro Baima, Matheus Freitas Cardoso de Azevedo, Adriana Ribas Andrade, Natália Souza Freitas Queiroz

Arq Gastroenterol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF ULCERATIVE COLITIS IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).
Júlio Pinheiro Baima, Marcello Imbrizi, Adriana Ribas Andrade, Liliane Andrade Chebli, Marjorie Costa Argollo

Arq Gastroenterol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukocytoclastic Vasculitis Secondary to Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Diseases: A Multicenter Retrospective Cohort Study.
Rogério Serafim Parra, Júlio Maria Fonseca Chebli, Liliana Andrade Chebli, Sérgio Figueiredo de Lima Junior, Manoel Alvaro Lins Neto

J Clin Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of Ustekinumab for Moderate to Severely Active Crohn's Disease: Results from an Early Access Program in Brazil.
Julio Maria Fonseca Chebli, Rogério Serafim Parra, Cristina Flores, Antonio Carlos Moraes, Rodrigo Bremer Nones

J Clin Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six-minute walk test predicts future decompensation in patients with compensated liver cirrhosis.
Diane Michela Nery Henrique, Carlos Alberto Mourao-Junior, Fabio Pace, Túlio Medina Dutra de Oliveira, Carla Malaguti, Julio Chebli

Rev Assoc Med Bras (1992)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous Monitoring of Azathioprine Metabolites in Erythrocytes of Crohn's Disease Patients by HPLC-UV.
Aline Correa Ribeiro, Luciane Henriques Furtado Barroso, Carlos Alberto Mourao-Junior, Julio Maria Fonseca Chebli, Jorge Willian Leandro Nascimento

J Chromatogr Sci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to "Six-minute walking test performance is associated with survival in cirrhotic patients" to the editor.
Carla Malaguti, Carlos Alberto Mourão-Junior, Júlio Maria Chebli

World J Hepatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIGH PREVALENCE OF NON-ADHERENCE TO ULCERATIVE COLITIS THERAPY IN REMISSION: KNOWING THE PROBLEM TO PREVENT LOSS.
Fernanda Cristina Zimmermann Franco, Mirella Chrispim Cerqueira de Oliveira, Pedro Duarte Gaburri, Danielle Cristina Zimmermann Franco, Júlio Maria Fonseca Chebli

Arq Gastroenterol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn's disease: a real-world multicenter Brazilian study.
Rogério Serafim Parra, Júlio Maria Fonseca Chebli, Natália Sousa Freitas Queiroz, Aderson Omar Mourão Cintra Damião, Matheus Freitas Cardoso de Azevedo

BMC Gastroenterol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Rectovaginal Fistula Using Fractionate CO Vaginal Laser: A Case Series.
Denise Gasparetti Drumond, Neila Maria de Góis Speck, Júlio Maria Fonseca Chebli, Camila de Moraes Sarmento Condé, Liliana Andrade Chebli

Photobiomodul Photomed Laser Surg· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil.
Ligia Yukie Sassaki, Sender J Miszputen, Roberto Luiz Kaiser Junior, Wilson R Catapani, Mauro Bafutto, Julio Pinheiro Baima

World J Gastroenterol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis